Altria Group (MO) FY2025 results: revenue $23.3 billion, down 3.1% on the year
Altria Group, Inc. (MO) reported revenue of $23.3 billion for fiscal 2025, the year ended 31 December 2025, down 3.1% on the year before. Net income was $6.9 billion, down 38.3%, and diluted earnings per share $4.12. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 1 raised, 4 new, 4 kept.
- Full-year adjusted EPS rose 4.4%: Full-year adjusted diluted EPS rose 4.4% to $5.42. Management tied the rise to higher adjusted OCI, fewer shares and a lower adjusted tax rate, partly offset by lower pension income and higher financing costs.
- Quarterly smokeable revenue fell on volume: Smokeable net revenues fell 2.7% in the fourth quarter on lower shipment volume and higher promotional investments, partly offset by higher pricing.
- Quarterly oral margin fell on SG&A: Fourth-quarter adjusted oral OCI fell 4.6% and margin fell 5.0 points to 64.5%, on higher SG&A and lower volume and mix, partly offset by pricing.
- Discount brands gained share: Fourth-quarter cigarette discount share reached 32.9%, up 2.6 points, which management linked to continued discretionary income pressures on ANCs.
- E-vapor impairments drove charges: Asset impairment, exit and implementation costs were $1.3 billion in the fourth quarter ($0.61 per share) and $2.2 billion for 2025, mostly from e-vapor goodwill and intangibles.
From this 10-K
Altria sells tobacco and nicotine products to United States consumers aged 21 and over. It describes its direction as Moving Beyond Smoking: transitioning adult smokers to smoke-free products, competing for existing smoke-free nicotine consumers, and looking for growth beyond the United States and beyond nicotine. It operates primarily within the United States and generates substantially all of its revenue from domestic customers. At 31 December 2025 the reportable segments were smokeable products, oral tobacco products and e-vapor products.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 23,279 | 24,018 | 24,483 | -3.1% | |
| Cost of revenue | 5,597 | 6,077 | 6,218 | -7.9% | |
| Gross profit | 14,542 | 14,367 | 14,284 | +1.2% | |
| Gross margin | 62.5% | 59.8% | 58.3% | ||
| Research and development | 195 | 208 | 220 | -6.2% | |
| Operating income | 9,899 | 11,241 | 11,547 | -11.9% | |
| Operating margin | 42.5% | 46.8% | 47.2% | ||
| Interest expense | 1,177 | 1,124 | 1,149 | +4.7% | |
| Pre-tax income | 9,389 | 13,658 | 10,928 | -31.3% | |
| Income tax | 2,442 | 2,394 | 2,798 | +2.0% | |
| Effective tax rate | 26.0% | 17.5% | 25.6% | ||
| Net income | 6,947 | 11,264 | 8,130 | -38.3% | |
| Net margin | 29.8% | 46.9% | 33.2% | ||
| Diluted EPS | $4.12 | $6.54 | $4.57 | -37.0% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 9,290 | 8,753 | 9,287 | +6.1% | |
| Capital expenditure | 216 | 142 | 196 | +52.1% | |
| Free cash flow | 9,074 | 8,611 | 9,091 | +5.4% | |
| Free cash flow margin | 39.0% | 35.9% | 37.1% | ||
| Cash from investing | -341 | 2,175 | -1,283 | ||
| Cash from financing | -7,615 | -11,491 | -8,374 | ||
| Depreciation and amortisation | 266 | 286 | 272 | -7.0% | |
| Buybacks | 1,000 | 3,400 | 1,000 | -70.6% | |
| Dividends paid | 6,960 | 6,845 | 6,779 | +1.7% | |
| Dividend per share | $4.16 | $4.00 | $3.84 | +4.0% | |
| Diluted shares, weighted | 1,683m | 1,718m | 1,777m | -2.0% | |
| Shares outstanding at period end | 1,674m | 1,691m | 1,763m | -1.0% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | -3,502 | -2,238 | -3,540 | ||
| Non-controlling interest | 50.0 | 50.0 | 50.0 | 0.0% | |
| Short-term borrowings | 0.0 | 0.0 | 0.0 | ||
| Debt | 25,709 | 24,926 | 26,233 | +3.1% | |
| Other liabilities | 12,760 | 12,439 | 15,827 | +2.6% | |
| Total liabilities and equity | 35,017 | 35,177 | 38,570 | -0.5% | |
| Fixed assets | 1,710 | 1,617 | 1,652 | +5.8% | |
| Goodwill | 5,787 | 6,945 | 6,791 | -16.7% | |
| Intangible assets | 11,876 | 12,973 | 13,686 | -8.5% | |
| Cash and equivalents | 4,474 | 3,127 | 3,686 | +43.1% | |
| Receivables | 263 | 177 | 71.0 | +48.6% | |
| Inventory | 1,070 | 1,080 | 1,215 | -0.9% | |
| Other assets | 9,837 | 9,258 | 11,469 | +6.3% | |
| Total assets | 35,017 | 35,177 | 38,570 | -0.5% |
10-K for the year ended 31 December 2025, filed 25 February 2026: the filing.